EMBL Courses and Conferences during the Coronavirus pandemic
With the onsite programme paused, many of our events are now being offered in virtual formats.
Registration is open as usual for many events, with back-up plans in place to move further courses and conferences online as necessary. Registration fees for any events affected by the COVID-19 disruption are fully refundable.
More information for participants of events at EMBL Heidelberg can be found here.
- CONFERENCE BUS SCHEDULE now available online!
- Final Programme is available online
- Fellowship. Succesful applicants have been notified
- Do you have something to tweet? Use this hashtag #EESTumour
Many oncogenes and tumour suppressor genes have been identified and mapped to signaling pathways that regulate cell growth and death. Dysregulation allows oncogenes and tumour suppressor genes to transform mammalian cells and cancers arise in conditions where multiple such events occur in the same cell. It has also been found that a subset of the cells present in a tumour, called cancer stem cells, retain the ability to self-renew and to give rise to all cell types in a particular cancer.
An emerging concept is that tumours also strongly depend on external signals for maintenance and expansion. To fully understand tumour development and progression, a deeper knowledge of the cross-talk between tumour cells and their microenvironment and the interactions between cancer cells and cancer stem cells is needed.
This symposium brings together researchers from complementary fields to enhance our understanding of the communication between cancer cells and their microenvironment. Important open questions are: Which signals do cancer cells transmit to and receive from the stroma and how do these signals promote malignant growth? What roles does the extracellular matrix play during neoplastic transformation? What is the contribution of immune cells to tumor progression? How is the inflammatory response of the tumour microenvironment regulated by the microbiota?
- Signaling pathways in stroma and cancers
- Cancer stem cells
- Cancer and the immune system
- Animal models of cancer
- Therapeutical implications: from bench to bedside
- Tumour microenvironment